TERT Promoter Mutations as Simple and Non-Invasive Urinary Biomarkers for the Detection of Urothelial Bladder Cancer in a High-Risk Region.
TERT promoter mutations
bladder cancer
non-invasive detection
opium
somatic mutations
telomerase
urinary biomarkers
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
18 Nov 2022
18 Nov 2022
Historique:
received:
11
08
2022
revised:
31
10
2022
accepted:
09
11
2022
entrez:
26
11
2022
pubmed:
27
11
2022
medline:
30
11
2022
Statut:
epublish
Résumé
Bladder cancer (BC) is the 10th most common cancer in the world. While there are FDA-approved urinary assays to detect BC, none have demonstrated sufficient sensitivity and specificity to be integrated into clinical practice. Telomerase Reverse Transcriptase (
Identifiants
pubmed: 36430798
pii: ijms232214319
doi: 10.3390/ijms232214319
pmc: PMC9696845
pii:
doi:
Substances chimiques
Telomerase
EC 2.7.7.49
Biomarkers, Tumor
0
DNA-Directed RNA Polymerases
EC 2.7.7.6
TERT protein, human
EC 2.7.7.49
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Cancer. 2010 Nov 15;116(22):5235-42
pubmed: 20665490
J Occup Environ Med. 2010 Apr;52(4):399-406
pubmed: 20357680
PLoS One. 2016 Feb 22;11(2):e0149756
pubmed: 26901314
Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1533-1541
pubmed: 29936728
Clin Biochem. 2019 Feb;64:60-63
pubmed: 30528938
Eur Urol. 2009 Sep;56(3):430-42
pubmed: 19576682
Eur Urol. 2016 Dec;70(6):916-919
pubmed: 27417036
Eur Urol. 2014 Feb;65(2):367-9
pubmed: 24035680
Oncotarget. 2016 Oct 11;7(41):67435-67448
pubmed: 27611947
J Cancer Res Ther. 2018 Apr-Jun;14(3):532-536
pubmed: 29893311
Int J Mol Sci. 2020 Aug 21;21(17):
pubmed: 32839402
Eur Urol. 2021 Jan;79(1):82-104
pubmed: 32360052
Eur Urol. 2011 Sep;60(3):484-92
pubmed: 21684071
Cancers (Basel). 2020 Nov 27;12(12):
pubmed: 33260905
BJU Int. 2017 Dec;120(6):755-765
pubmed: 29168333
EBioMedicine. 2020 Mar;53:102643
pubmed: 32081602
Urology. 2003 Jan;61(1):109-18; discussion 118
pubmed: 12559279
Virchows Arch. 2014 Aug;465(2):119-33
pubmed: 25048572
J Cancer. 2019 Jul 8;10(17):4038-4044
pubmed: 31417648
Elife. 2018 Mar 20;7:
pubmed: 29557778
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Clin Oncol. 2001 Feb 1;19(3):666-75
pubmed: 11157016
Arch Iran Med. 2021 Mar 01;24(3):167-176
pubmed: 33878874
Eur J Cancer. 2015 May;51(8):969-76
pubmed: 25843513
Proc Natl Acad Sci U S A. 2021 Sep 21;118(38):
pubmed: 34518220
Eur Urol. 2016 Jul;70(1):93-105
pubmed: 26935559
Science. 2015 Feb 27;347(6225):1006-10
pubmed: 25722414
J Egypt Natl Canc Inst. 2012 Dec;24(4):151-9
pubmed: 23159285
Br J Cancer. 2017 Aug 8;117(4):583-587
pubmed: 28683471
Asian Pac J Cancer Prev. 2021 Oct 01;22(10):3385-3391
pubmed: 34711016
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17426-31
pubmed: 24101484
Eur Urol. 2014 Feb;65(2):360-6
pubmed: 24018021
Int J Cancer. 2000 Apr 15;86(2):289-94
pubmed: 10738259
Eur Urol. 2016 Mar;69(3):438-47
pubmed: 26508308
BJU Int. 2019 Sep;124(3):532-544
pubmed: 31077629
Int J Epidemiol. 2022 Jun 13;51(3):830-838
pubmed: 35244716
Cancer Res. 2013 Dec 15;73(24):7162-7
pubmed: 24121487
BMJ Glob Health. 2021 Nov;6(11):
pubmed: 34844997
Adv Anat Pathol. 2016 Jul;23(4):193-201
pubmed: 27233050
Stat Med. 2007 May 10;26(10):2170-83
pubmed: 16927452
EBioMedicine. 2019 Jun;44:431-438
pubmed: 31122840
Nat Rev Dis Primers. 2017 Apr 13;3:17022
pubmed: 28406148